Compare SLDP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLDP | EVO |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | Germany |
| Employees | 230 | 4766 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.7M | 821.2M |
| IPO Year | N/A | N/A |
| Metric | SLDP | EVO |
|---|---|---|
| Price | $3.16 | $2.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | $7.00 |
| AVG Volume (30 Days) | ★ 3.2M | 108.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.88 | N/A |
| Revenue Next Year | $10.00 | $7.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $2.31 |
| 52 Week High | $8.86 | $4.80 |
| Indicator | SLDP | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 30.64 |
| Support Level | $2.94 | $2.31 |
| Resistance Level | $4.70 | $3.78 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 27.88 | 16.15 |
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.